Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Stereotaxis and CardioFocus partner to develop a robotic pulsed field ablation system for heart arrhythmias, combining robotic navigation with proven PFA technology.

flag Stereotaxis and CardioFocus have partnered to develop and commercialize the first robotic pulsed field ablation system for treating heart arrhythmias, combining Stereotaxis’s robotic magnetic navigation with CardioFocus’s CE-marked Centauri PFA System. flag Preclinical testing shows the integrated system creates safe, deep, and durable lesions. flag The companies plan to advance the technology into clinical trials, pursue regulatory approval, and bring the system to patients, building on their combined experience from over 150,000 robotic procedures and 9,000 PFA treatments.

3 Articles